Maria Sklodowska-Curie National Research Institute of Oncology
Maria Sklodowska-Curie National Research Institute of Oncology
Explore linked clinical trials.28 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2026-10-07 | NCT07787429 | |
| Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients | Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, histiocytosis, interstitial lung disease, lung disorder, lymphatic system disorder, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-10-07 | NCT04943224 | |
| Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging | Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, histiocytosis, interstitial lung disease, lung disorder, lymphatic system disorder, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-07 | NCT04943211 | |
| Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis | Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, histiocytosis, interstitial lung disease, lung disorder, lymphatic system disorder, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-10-07 | NCT04943198 | |
| The STOP-MED CTRCD Trial | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury | Recruiting | Phase 4 | 2026-07-07 | NCT06183437 | |
| Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Not applicable | 2026-06-25 | NCT07669298 | |
| Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Active, not recruiting | Phase 3 | 2026-06-16 | NCT05271162 | |
| Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial | Exostoses, Foot Diseases, Heel Spur Syndrome, bone disorder, fasciitis, heel spur, hyperostosis, musculoskeletal system disorder, plantar fasciitis | Recruiting | Not applicable | 2026-04-22 | NCT07546240 | |
| A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm | Recruiting | Not stated | 2026-02-23 | NCT04678011 | |
| A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm | Recruiting | Not stated | 2026-02-23 | NCT04677998 | |
| Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2025-12-08 | NCT06128863 | |
| NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery | Cerebrospinal Fluid Otorrhea, Craniocerebral Trauma, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Pituitary Neoplasms, Signs and Symptoms, brain disorder, central nervous system cancer, central nervous system disorder, cerebrospinal fluid leak, endocrine system disorder, hypothalamic disorder, hypothalamic neoplasm, injury, malignant endocrine neoplasm, neoplasm, nervous system disorder, nervous system injury, pituitary gland disorder, supratentorial cancer | Recruiting | Not applicable | 2025-10-14 | NCT07216157 | |
| Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy | Cancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast disorder, breast neoplasm, carcinoma, cervix disorder, clear cell renal carcinoma, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, kidney cancer, kidney disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, renal cell carcinoma, skin disorder, skin neoplasm, triple-negative breast carcinoma, urinary system disorder, uterine corpus cancer, uterine disorder | Not yet recruiting | Phase 2 | 2025-05-16 | NCT06976021 | |
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" | CD20-positive Acute Lymphoblastic Leukemia | Recruiting | Phase 2 | 2025-04-24 | NCT04920968 | |
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, malignant tumor of nasopharynx, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-04-24 | NCT04875611 | |
| Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes | Acute Myeloid Leukemia Myelodysplastic Syndromes | Active, not recruiting | Phase 2 | 2025-04-24 | NCT04861207 | |
| Functional Abdominal Wall Reconstruction | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, prune belly syndrome | Active, not recruiting | Not stated | 2025-04-15 | NCT06928974 | |
| Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. | Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm | Recruiting | Phase 2 | 2025-04-02 | NCT05563467 | |
| Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy | Local Recurrence of Malignant Tumor of Prostate; Radiotherapy | Recruiting | Phase 2 | 2025-03-13 | NCT06201078 | |
| Understanding the Transition from Normal Melanocytes to Nevus to Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, large congenital melanocytic nevus, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not stated | 2025-02-27 | NCT06605417 | |
| Stereotactic Radiosurgery in the Treatment of Essential Tremor | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Phase 2 | 2025-02-12 | NCT06821906 | |
| 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2025-02-10 | NCT06449781 | |
| MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, cutaneous melanoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not stated | 2024-09-19 | NCT06602648 | |
| Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2024-06-25 | NCT06472583 | |
| Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Not applicable | 2024-06-25 | NCT06472570 |